Latency, activation, and binding proteins of TGF-β

Microscopy Research and Technique

Volumn 52, Issue 4, 2001, Pages 354-362

  Koli, Katri ^a   Saharinen, Juha ^a   Hyytiäinen, Marko ^a   Penttinen, Carita ^a   Keski Oja, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Extracellular matrix; Latent TGF complex; LTBP; TGF ; TGF activation

Indexed keywords

CELL PROLIFERATION; CLONING; MAMMALS; STEROID HORMONES;

BINDING PROTEINS; EXTRACELLULAR MATRICES; GROWTH FACTOR; LATENT TGF-Β BINDING PROTEIN; LATENT TGF-Β COMPLEX; TGF-Β; TGF-Β ACTIVATION;

CHEMICAL ACTIVATION;

BINDING PROTEIN; RETINOID; STEROID HORMONE; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

ANIMAL CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW; TISSUE REGENERATION; WOUND HEALING;

MAMMALIA;

EID: 0035865279     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G     Document Type: Review

References (103)

1. Abe M, Oda N, Sato Y. 1998. Cell-associated activation of latent transforming growth factor-β by calpain. J Cell Physiol 174:186-193.
2. Antonelli-Orlidge A, Saunders K, Smith S, D'Amore P. 1989. An activated form of transforming growth factor-β is produced by co-cultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548.
3. Arteaga CL, Coffey RJJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM. 1990. Growth stimulation of human breast cancer cells with anti-transforming growth factor-β antibodies: evidence for negative autocrine regulation by transforming growth factor-β. Cell Growth Diff 1:367-374.
4. Barcellos-Hoff M. 1993. Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 53:3880-3886.
5. Barcellos-Hoff M, Dix T. 1996. Redox-mediated activation of latent transforming growth factor-β1. Mol Endocrinol 10:1077-1083.
6. Barcellos-Hoff M, Derynck R, Tsang M, Weatherbee J. 1994. Transforming growth factor-β activation in irradiated murine mammary gland. J Clin Invest 93:892-899.
7. Bassols A, Massague J. 1988. Transforming growth factor-β regulates the expression and structure of extracellular matrix chondroitin/ dermatan sulfate proteoglycans. J Biol Chem 263:3039-3045.
8. Boulanger J, Reyes-Moreno C, Koutsilieris M. 1995. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor-β1 in MG-63 human osteosarcoma cells. Int J Cancer 61:692-697.
9. Brown P, Wakefield L, Levinson A, Sporn M. 1990. Physicochemical activation of recombinant latent transforming growth factor-β's 1, 2, and 3. Growth Factors 3:35-43.
10. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M. 1992. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 267:19027-19030.
11. Colletta A, Wakefield L, Howell F, Danielpour D, Baum M, Sporn M. 1991. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor-β. J Clin Invest 87:277-283.
12. Crawford S, Stellmach V, Murphy-Ullrich J, Ribeiro S, Lawler J, Hynes R, Boivin G, Bouck N. 1998. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93:1159-1170.
13. Dallas SL, Park-Snyder S, Miyazono K, Twardzik D, Mundy GR, Bonewald LF. 1994. Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGFβ-binding protein. J Biol Chem 269:6815-6821.
14. Danielpour D, Kim KY, Winokur TS, Sporn MB. 1991. Differential regulation of the expression of transforming growth factor-βs 1 and 2 by retinoinc acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J Cell Physiol 148:235-244.
15. de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, Seifert J, Bodmer S, Fontana A, Hofer E. 1987. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 6:3673-3677.
16. Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID, Handford PA. 1996. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85:597-605.
17. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. 1995. Processing of transforming growth factor-β1 precursor by human furin convertase. J Biol Chem 270:10618-10624.
18. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, Heath JK. 1987. Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904.
19. Eklöv S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K, Nilsson S. 1993. Lack of the latent transforming growth factor-β binding protein in malignant, but not benign prostatic tissue. Cancer Res 53:3193-3197.
20. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Vergilio JA, Nicholson AC. 1993. Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem 268:11951-11958.
21. Gentry LE, Lioubin MN, Purchio AF, Marquardt H. 1988. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor-β to the mature polypeptide. Mol Cell Biol 8:4162-4168.
22. Gibson MA, Hatzinikolas G, Davis EC, Baker E, Sutherland GR, Mecham RP. 1995. Bovine latent transforming growth factor-β1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol 15:6932-6942.
23. Gibson MA, Finnis ML, Kumaratilake JS, Cleary EG. 1998. Microfibril-associated glycoprotein-2 (MAGP-2) is specifically associated with fibrillin-containing microfibrils but exhibits more restricted pattern of tissue localization and developmental expression than its structural relative MAGP-1. J Histochem Cytochem 46:871-886.
24. Giltay R, Kostka G, Timpl R. 1997. Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-β binding proteins. FEBS Lett 411:164-168.
25. Gleizes PE, Beavis RC, Mazzieri R, Shen B, Rifkin DB. 1996. Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor-β 1. J Biol Chem 271:29891-29896.
26. Glick A, Flanders K, Danielpour D, Yuspa S, Sporn M. 1989. Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul 1:87-97.
27. Godar S, Horejsi V, Weidle UH, Binder BR, Hansmann C, Stockinger H. 1999. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-β1. Eur J Immunol 29:1004-1013.
28. Gong W, Roth S, Michel K, Gressner AM. 1998. Isoforms and splice variant of transforming growth factor-β binding protein in rat hepatic stellate cells. Gastroenterology 114:352-363.
29. Gray A, Mason A. 1990. Requirement for activin A and transforming growth factor-β1 pro-regions in homodimer assembly. Science 247: 1328-1330.
30. Heino J, Ignotz RA, Hemler ME, Crouse C, Massagué J. 1989. Regulation of cell adhesion receptors by transforming growth factor-β. Concomitant regulation of integrins that share a common β1 subunit. J Biol Chem 264:380-388.
31. Horimoto M, Kato J, Takimoto R, Terui T, Mogi Y, Niitsu Y. 1995. Identification of a transforming growth factor-β1 activator derived from a human gastric cancer cell line. Br J Cancer 72:676-682.
32. Huang X, Wu J, Cass D, Erle D, Corry D, Young S, Farese R, Sheppard D. 1996. Inactivation of the integrin β6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol 133:921-928.
33. Huber D, Philipp J, Fontana A. 1992. Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J Immunol 148:277-284.
34. Hyytiäinen M, Taipale J, Heldin CH, Keski-Oja J. 1998. Recombinant latent transforming growth factor-β-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem 273:20669-20676.
35. Ignotz RA, Massagué J. 1986. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345.
36. Jullien P, Berg T, Lawrence D. 1989. Acidic cellular environments: activation of latent TGF-β and sensitization of cellular responses to TGF-β and EGF. Int J Cancer 43:886-891.
37. Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin CH. 1990. TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61:1051-1061.
38. Kanzaki T, Shiina R, Saito Y, Oohashi H, Morisaki N. 1998. Role of latent TGF-β1 binding protein in vascular remodeling. Biochem Biophys Res Commun 246:26-30.
39. Kerr LD, Miller DB, Matrisian LM. 1990. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61:267-278.
40. Khalil M. 1999. TGF-β: from latent to active. Microbes Infect 1:1255-1263.
41. Knabbe C, Lippman M, Wakefield L, Flanders K, Kasid A, Derynck R, Dickson R. 1987. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428.
42. Kojima S, Rifkin DB. 1993. Mechanism of rretinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol 155:323-332.
43. 3 and calcipotriol decrease pericellular plasminogen activator activity in cultured keratinocytes. J Invest Dermatol 101:706-712.
44. 3 and calcipotriol enhance the secretion of transforming growth factor-β1 and -β2 in cultured murine keratinocytes. Growth Factors 8:153-163.
45. 3 enhances the expression of transforming growth factor-β1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res 55:1540-1546.
46. Koli K, Lohi J, Hautanen A, Keski-Oja J. 1991. Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-β1. Eur J Biochem 199:337-345.
47. Koski C, Saharinen J, Keski-Oja J. 1999. Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-β binding protein-1 (LTBP-1) in a cell type-specific manner. J Biol Chem 274:32619-32630.
48. Laiho M, Saksela O, Andreasen P, Keski-Oja J. 1986. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol 106:2403-2410.
49. Laiho M, Saksela O, Keski-Oja J. 1987. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 262:17467-17474.
50. Lawrence D, Pircher R, Kryceve-Martinerie C, Jullien P. 1984. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 121:184-188.
51. Lawrence D, Pircher R, Jullien P. 1985. Conversion of a high molecular weight latent TGF-β from chicken embryo fibroblasts into a low molecular weight active TGF-β under acidic conditions. Biochem Biophys Res Commun 133:1026-1034.
52. Lecuit T. 1996. Two distinct mechanisms for long-range patterning by decapentaplegic in the Drosophila wing. Nature 381:387-393.
53. Lopez-Casillas F, Wrana JL, Massagué J. 1993. Betaglycan presents ligand to the TGF-β signaling receptor. Cell 73:1435-1444.
54. Lyons RM, Keski-Oja J, Moses HL. 1988. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol 106:1659-1665.
55. Lyons RM, Gentry LE, Purchio AF, Moses HL. 1990. Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J Cell Biol 110:1361-1367.
56. Massagué J, Like B. 1985. Cellular receptors for type-β transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem 260:2636-2645.
57. Massagué J, Attisano L, Wrana JL. 1994. The TGF-β family and its composite receptors. Trends Cell Biol 4:172-178.
58. Michel K, Roth S, Trautwein C, Gong W, Flemming P, Gressner AM. 1998. Analysis of the expression pattern of the latent transforming growth factor-β binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinasesensitive hinge region. Hepatology 27:1592-1599.
59. Miyazono K, Heldin CH. 1989. Role for carbohydrate structures in TGF-β1 latency. Nature 338:158-160.
60. Miyazono K, Olofsson A, Colosetti P, Heldin CH. 1991. A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J 10:1091-1101.
61. Miyazono K, Thyberg J, Heldin CH. 1992. Retention of the transforming growth factor-β1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem 267:5668-5675.
62. Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H. 1993. Immunoelectron microscopic localization of transforming growth factor-β1 and latent transforming growth factor-β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 53:183-190.
63. Morén A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L, ten Dijke P, Miyazono K, Heldin CH. 1994. Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J Biol Chem 269:32469-32478.
64. Munger JS, Harpel JG, Giancotti FG, Rifkin DB. 1998. Interactions between growth factors and integrins: latent forms of transforming growth factor-β are ligands for the integrin αvβ1. Mol Biol Cell 9:2627-2638.
65. Munger JS, Huang X, Kawakatsu H, Griffiths M, Dalton S, Wu J, Pittet J-F, Kaminski N, Garat C, Matthay M, Rifkin DB, Sheppard D. 1999. The integrin avβ6 binds and activates latent TGF-β1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328.
66. Murphy-Ullrich J, Schultz-Cherry S, Höök M. 1992. Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell 3:181-188.
67. Nunes I, Gleizes PE, Metz CN, Rifkin DB. 1997. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J Cell Bio 136:1151-1163.
68. Öklu R, Hesketh T, Metcalfe J, Kemp P. 1998a. Expression of alternatively spliced human latent transforming growth factor-β binding protein-1. FEBS Lett 435:143-148.
69. Öklu R, Metcalfe JC, Hesketh TR, Kemp PR. 1998b. Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-β binding protein-1. FEBS Lett 425:281-285.
70. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engström U, Heldin CH. 1992. Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 267:19482-19488.
71. Olofsson A, Ichijo H, Morén A, ten Dijke P, Miyazono K, Heldin CH. 1995. Efficient association of an amino-terminally extended form of human latent transforming growth factor-β binding protein with the extracellular matrix. J Biol Chem 270:31294-31297.
72. Oursler M, Riggs B, Spelsberg T. 1993. Glucocorticoid-induced activation of latent transforming growth factor-β by normal human osteoblast-like cell. Endocrinology 133:2187-2196.
73. Paralkar V, Vukicevic S, Reddi A. 1991. Transforming growth factor-β type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev Biol 143:303-308.
74. Pearson C, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. 1988. Tenascin: cDNA cloning and induction by TGF-β. EMBO J 17:2977-2982.
75. Piek E, Heldin C-H, ten Dijke P. 1999. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13:2105-2124.
76. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE. 1999. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J Biol Chem 274:13586-13593.
77. Roberts A, Sporn M. 1996. Transforming growth factor-β. In The Molecular and Cellular Biology of Wound Repair, Clark R, ed. (New York, USA: Plenum Press), pp. 275-308.
78. Rosenbloom J, Abrams WR, Mecham R. 1993. Extracellular matrix 4: the elastic fiber. FASEB J 7:1208-1218.
79. Saharinen J, Keski-Oja J. 2000. Specific sequence motif of 8-Cys repeats of TGF-β binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β. Mol Biol Cell 11:2691-2704.
80. Saharinen J, Hyytiäinen M, Taipale J, Keski-Oja J. 1999. Latent transforming growth factor-β-binding proteins (LTBPs): Structural extracellular matrix proteins for targeting TGF-β action. Cytokine and Growth Factor Reviews 10:99-117.
81. Saharinen J, Taipale J, Keski-Oja J. 1996. Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1. EMBO J 15:245-253.
82. Saharinen J, Taipale J, Monni O, Keski-Oja J. 1998. Identification and characterization of a new latent transforming growth factor-β-binding protein, LTBP-4. J Biol Chem 273:18459-18469.
83. Sakai LY, Keene DR. 1994. Fibrillin: monomers and microfibrils. Methods Enzymol 245:29-52.
84. Salo J, Lehenkari P, Mulari M, Metsikkö K, Väänänen HK. 1997. Removal of osteoclast bone resorption products by transcytosis. Science 276:270-273.
85. Sato Y, Rifkin D. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J Cell Biol 109:309-315.
86. Schultz-Cherry S, Murphy-Ullrich J. 1993. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923-932.
87. Schultz-Cherry S, Lawler J, Murphy-Ullrich J. 1994a. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β. J Biol Chem 269:26783-26788.
88. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE. 1994b. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem 269:26775-26782.
89. Sporn MB, Roberts AB. 1992. Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119:1017-1021.
90. Taipale J, Koli K, Keski-Oja J. 1992. Release of transforming growth factor-β1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 267: 25378-25384.
91. Taipale J, Miyazono K, Heldin CH, Keski-Oja J. 1994. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 124:171-181.
92. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. 1995. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 270:4689-4696.
93. Taipale J, Saharinen J, Hedman K, Keski-Oja J. 1996. Latent transforming growth factor-β1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 44:875-889.
94. Taipale J, Saharinen J, Keski-Oja J. 1998. Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv Cancer Res 75:87-134.
95. Tsuji T, Okada F, Yamaguchi K, Nakamura T. 1990. Molecular cloning of the large subunit of transforming growth factor type-β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci USA 87:8835-8839.
96. Tucker R, Shipley G, Moses HL, Holley R. 1984. Growth inhibitor from BSC-1 cells closely related to platelet type-β transforming growth factor. Science 226:705-707.
97. Unsold C, Hyytiäinen M, Bruckner-Tuderman L, Keski-Oja J. 2001. Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 114:187-197.
98. Yamaguchi Y, Mann D, Ruoslahti E. 1990. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281-284.
99. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. 1991. Cell surface, heparin-like molecules are required for binding of fibroblast growth factor to its high affinity receptor. Cell 64:841-848.
100. Yin W, Smiley E, Bonadio J. 1998. Alternative splicing of LTBP-3. Biochem Biophys Res Commun 245:454-458.
101. Yin W, Smiley E, Germiller J, Mecham RP, Florer JB, Wenstrup RJ, Bonadio J. 1995. Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J Biol Chem 270:10147-10160.
102. Yu Q, Stamenkovic I. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14:163-76.
103. Zhang H, Apfelroth SD, Hu W, Davis EC, Sanguineti C, Bonadio J, Mecham RP, Ramirez F. 1994. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 124:855-863.